blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1377591

EP1377591 - TUMOUR INHIBITING GALLIUM COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.05.2007
Database last updated on 25.09.2024
Most recent event   Tooltip18.01.2013Lapse of the patent in a contracting statepublished on 20.02.2013  [2013/08]
Applicant(s)For all designated states
Faustus Forschungs Cie. Translational Cancer Research GmbH
Grimmaische Strasse 2-4
04109 Leipzig / DE
[2006/26]
Former [2004/02]For all designated states
Faustus Forschungs Cie. Translational Cancer Research GmbH
Grimmaische Strasse 2-4
04109 Leipzig / DE
Inventor(s)01 / KEPPLER, Bernhard
Luisenstrasse 35
68766 Hockenheim / DE
 [2004/02]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2004/02]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date02708371.628.03.2002
[2004/02]
WO2002EP03560
Priority number, dateDE200111652703.04.2001         Original published format: DE 10116527
[2004/02]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO02081484
Date:17.10.2002
Language:DE
[2002/42]
Type: A1 Application with search report 
No.:EP1377591
Date:07.01.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 17.10.2002 takes the place of the publication of the European patent application.
[2004/02]
Type: B1 Patent specification 
No.:EP1377591
Date:28.06.2006
Language:DE
[2006/26]
Search report(s)International search report - published on:EP17.10.2002
ClassificationIPC:C07F5/00
[2004/02]
CPC:
C07D213/53 (EP,US); A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/02]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:TUMORHEMMENDE GALLIUMVERBINDUNGEN[2004/02]
English:TUMOUR INHIBITING GALLIUM COMPOUNDS[2004/02]
French:COMPOSES DE GALLIUM ANTITUMORAUX[2004/02]
Entry into regional phase03.11.2003National basic fee paid 
03.11.2003Designation fee(s) paid 
03.11.2003Examination fee paid 
Examination procedure31.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
03.11.2003Examination requested  [2004/02]
11.02.2004Despatch of a communication from the examining division (Time limit: M06)
13.08.2004Reply to a communication from the examining division
30.12.2005Communication of intention to grant the patent
08.05.2006Fee for grant paid
08.05.2006Fee for publishing/printing paid
Opposition(s)29.03.2007No opposition filed within time limit [2007/23]
Fees paidRenewal fee
30.03.2004Renewal fee patent year 03
30.03.2005Renewal fee patent year 04
28.03.2006Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY28.06.2006
FI28.06.2006
IT28.06.2006
NL28.06.2006
TR28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
[2013/08]
Former [2013/07]CY28.06.2006
FI28.06.2006
IT28.06.2006
NL28.06.2006
TR28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
Former [2009/47]CY28.06.2006
FI28.06.2006
IT28.06.2006
NL28.06.2006
TR28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
Former [2009/42]CY28.06.2006
FI28.06.2006
IT28.06.2006
NL28.06.2006
TR28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
IE28.03.2007
Former [2009/38]CY28.06.2006
FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
IE28.03.2007
Former [2009/13]FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
IE28.03.2007
Former [2008/29]FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
AT28.03.2007
GB28.03.2007
IE28.03.2007
Former [2008/21]FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
GR29.09.2006
ES09.10.2006
PT28.11.2006
GB28.03.2007
IE28.03.2007
Former [2008/10]FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
ES09.10.2006
PT28.11.2006
IE28.03.2007
Former [2007/38]FI28.06.2006
IT28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
ES09.10.2006
PT28.11.2006
Former [2007/22]FI28.06.2006
NL28.06.2006
DK28.09.2006
SE28.09.2006
ES09.10.2006
PT28.11.2006
Former [2007/19]FI28.06.2006
NL28.06.2006
SE28.09.2006
ES09.10.2006
PT28.11.2006
Former [2007/12]FI28.06.2006
SE28.09.2006
ES09.10.2006
PT28.11.2006
Former [2006/52]FI28.06.2006
SE28.09.2006
Former [2006/48]SE28.09.2006
Cited inInternational search[YD]US4596710  (COLLERY PHILIPPE [FR]) [YD] 1-5* the whole document *;
 [Y]US4657903  (SCOVILL JOHN P [US], et al) [Y] 1-5 * column 2 *;
 [YD]US5484778  (KENNEY MALCOLM E [US], et al) [YD] 1-5 * the whole document *;
 [Y]  - KLAYMAN, D. L. ET AL, "2-Acetylpyridine thiosemicarbazones. 6. 2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents", ARZNEIM.-FORSCH. (1983), 33(7), 909-12, XP001071299 [Y] 1-5 * Zusammenfassung; S. 910, Verbindungen IV 2, VI 7, 17 *
 [Y]  - HALL, IRIS H. ET AL, "The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells", ANTI-CANCER DRUGS (1993), 4(2), 231-40, XP002079621 [Y] 1-5 * S. 232, Verbindung #4 *
 [Y]  - KOVALA-DEMERTZI, DIMITRA ET AL, "Palladium(II) complexes of 2-acetylpyridine N(4)-propyl-, N(4)-dipropyl- and 3-hexamethyleneiminylthiosemicarbazones with potentially interesting biological activity. Synthesis, spectral properties, antifungal and in vitro antitumor activity", POLYHEDRON (1997), 16(20), 3625-3633, XP002201201 [Y] 1-5 * S. 3626, Verbindung 7 *

DOI:   http://dx.doi.org/10.1016/S0277-5387(97)00107-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.